BridgeMD
New treatment option for Percutaneous Nephrolithotripsy (PCNL)
Official title Adding Dexmedetomidine or Tramadol to Paracetamol- An Effort to Attenuate Catheter Related Bladder Discomfort
ClinicalTrials.gov ID: NCT06274333
What this study is testing
What is Dexmedetomidine 0.5 mic/kg?
Dexmedetomidine 0.5 mic/kg is an investigational medicine, being studied as a potential treatment for percutaneous nephrolithotripsy (pcnl).
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The insertion of a urinary catheter in a patient undergoing a surgical procedure, especially urinary interventions, may lead to catheter-related bladder discomfort (CRBD) with varying degrees of severity during the postoperative period. Paracetamol is a drug with proven efficacy for the management of mild and moderate postoperative pain.
- Phase 3: a large, late-stage study
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 to 50, men only
You may be able to join if
- Age from 20 - 50 years
- ASA (The American Society of Anesthesiologists) I or II,
- undergo percutaneous nephrolithotomy (PCNL)
You likely can't join if
- Patients with history of psychotic illnesses
- Opioid users
- Bladder obstruction,
- Benign prostatic hyperplasia
- Overactive bladder (OAB) defined as frequency \_3 times at night or \_8 times within 24 hours.
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Cairo Governorate, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 20 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Cairo Governorate, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.